Viscosupplementation Market Size, Share, Growth, Trends and Product Analysis
by Susan Hill Business ConsultantThe global viscosupplementation market size is expected to
reach USD 7.1 billion by 2026, based on a new report by Grand View Research,
Inc. It is projected to expand at a CAGR of 9.11% during the forecast period.
The market is expected to observe an exponential growth attributed to the
increasing incidence of osteoarthritis, wounds, gingivitis, and ulcers coupled
with growing geriatric population.
Estimates published by the World Health Organization
(WHO) suggest that the global population of the age group 65 years and above is
anticipated to rise from 7% in 2000 to 16% in 2050. A consequence of this
growth in geriatric population will be the rise in prevalence of obesity and
osteoarthritis. Along with the growing preference for minimally invasive
surgeries, a global increase in the target population is expected to
significantly propel demand for viscosupplementations throughout the forecast
period.
Further
key findings from the study suggest:
- Three injections segment led the market in 2018, closely followed by
the single injection segment. This growth can be accredited to the
prolonged presence and holding a significant market share
- Single injection segment is anticipated to be one of the fastest
growing segments owing to the benefits of the product such as increased
convenience and reduced hospital visits and adverse effects such as pain
- Geographically, Asia Pacific held the largest market share in 2018
and is expected to maintain its position during the forecast period, owing
to the presence of a sizeable geriatric population, which is more
susceptible to disorders such as osteoarthritis and rheumatoid arthritis. Moreover, the
growing demand for minimally invasive procedures is a significant factor
contributing to the regional growth
- Due to the presence of high unmet medical needs, growing awareness
about applications of minimally invasive techniques, and increasing
disposable income; Europe viscosupplementation market is expected to grow
at a lucrative CAGR in the forthcoming years
- Some key industry contributors are Sanofi; Anika Therapeutics, Inc.;
Seikagaku Corporation; Zimmer Holdings Inc.; Bioventus; Ferring B.V.;
Lifecore Biomedical, LLC; and LG Life Sciences Ltd
Access
full research report on global viscosupplementation market:
www.grandviewresearch.com/industry-analysis/viscosupplementation-market
Sponsor Ads
Created on Feb 12th 2020 03:00. Viewed 301 times.